Subscribe to Newsletter

Claes Gustafsson

Co-Founder & Chief Commercial Officer at ATUM

Content by Claes Gustafsson:

 Manufacture Bioprocessing - Upstream & Downstream

Optimizing mRNA Sequence Design

| Claes Gustafsson | 4 min read

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker